Expand AVXL Menu
AVXL MENU

AVXL Stock Posts


AVXL stock declines -21.2% in premarket,

Premarket Decliner

AVXL Anavex Life Sciences Corp.4.19-0.25-5.6%

Premarket:3.30-0.89 (-21.2%)

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease

Globe NewswireWed, 25-Mar 7:30 AM
Unusual Option Volume

AVXL Anavex Life Sciences Corp.4.40+0.34 (+8.4%)

Anavex Life Sciences Corp. trades 7,644 contracts. The company has the following event: AD/PD 2026 Conference on Mar 23, 2026. News: Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer's Disease
View Details...
$AVXL Earnings February 09 BMO. 20-Feb-26 Straddle Implies ±11.2% Move vs Prev. Move +12.3%
Unusual Option Volume

AVXL Anavex Life Sciences Corp.3.98-0.13 (-3.2%)

Anavex Life Sciences Corp. trades 7,413 contracts. The company has the following event: 44th Annual J.P. Morgan Healthcare Conference on Jan 14, 2026.
View Details...
Unusual Option Volume

AVXL Anavex Life Sciences Corp.4.30+0.63 (+17.2%)

Anavex Life Sciences Corp. trades 5,434 contracts. The company has the following event: 44th Annual J.P. Morgan Healthcare Conference on Jan 14, 2026.
View Details...
Unusual Option Volume

AVXL Anavex Life Sciences Corp.3.39-0.21 (-5.8%)

Anavex Life Sciences Corp. trades 9,376 contracts. AVXL will report earnings on Nov 25, 2025. The company has the following event: 44th Annual J.P. Morgan Healthcare Conference on Jan 14, 2026.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes